Torrent Pharma: Steady Growth and Margin Visibility Outlook Intact. Maintain ADD
The recent ~9% stock price correction for Torrent Pharma (TRP) was due to a ~3% stake sale by the promoter group (Mehta Family)
310 Views
Torrent Pharmaceuticals (TRP IN): Domestic Business Drives Q2 Result; Margin Expansion to Continue
Torrent Pharmaceuticals reported 17% YoY increase in net profit on 9% YoY revenue growth and expanding EBITDA margin in Q2FY25. Going ahead, the...
247 Views
Torrent Pharma: Focus on branded generics and profitability. Maintain ADD
In its FY24 annual report, Torrent Pharma (TRP) has highlighted strategic themes that align with its short, medium and long-term goals
217 Views
Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release
The two pre-IPO investors have launched a block to sell around US$591m worth of Mankind Pharma shares. Since the lockup on the shares expired not...
604 Views
2023 High Conviction Update: Cipla (CIPLA IN)- Stellar Q1FY24 Performance; Margin Guidance Raised
Q1FY24 result beat expectations. Both India and the U.S. businesses reported record high revenue. EBITDA rose to multi-quarter high. For FY24,...
387 Views